MENU
+Compare
KALA
Stock ticker: NASDAQ
AS OF
Apr 9, 04:59 PM (EDT)
Price
$3.86
Change
+$0.36 (+10.29%)
Capitalization
22.58M

KALA Kala BIO Forecast, Technical & Fundamental Analysis

Kala Bio Inc is a biopharmaceutical company... Show more

KALA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for KALA with price predictions
Apr 08, 2025

KALA's RSI Oscillator stays in oversold zone for 6 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where KALA advanced for three days, in of 215 cases, the price rose further within the following month. The odds of a continued upward trend are .

KALA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on KALA as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for KALA turned negative on March 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KALA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KALA entered a downward trend on April 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.957) is normal, around the industry mean (12.887). P/E Ratio (0.000) is within average values for comparable stocks, (62.213). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.737). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (241.309).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. KALA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KALA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
KALA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a developer of ophthalmic treatments based on its mucosal penetrating product platform

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1167 Massachusetts Avenue
Phone
+1 781 996-5252
Employees
43
Web
https://www.kalarx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACEL9.980.17
+1.73%
Accel Entertainment
KFS7.720.04
+0.52%
Kingsway Financial Services
CBZ70.03-0.96
-1.35%
CBIZ
RMD204.54-8.46
-3.97%
ResMed
ATER1.60-0.16
-9.09%
Aterian

KALA and Stocks

Correlation & Price change

A.I.dvisor tells us that KALA and PALI have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KALA and PALI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALA
1D Price
Change %
KALA100%
-6.42%
PALI - KALA
31%
Poorly correlated
-5.96%
ARDX - KALA
28%
Poorly correlated
-2.70%
ENTX - KALA
27%
Poorly correlated
-0.61%
CRGX - KALA
27%
Poorly correlated
-4.22%
UNCY - KALA
27%
Poorly correlated
+2.02%
More